Geographic Atrophy

Researchers at the National Institutes of Health (NIH) have found that taking a daily supplement containing antioxidant vitamins and minerals...

Macular Disease Foundation Australia (MDFA) has launched Eye Connect, a comprehensive support service for people living with macular disease and...

Optometrists have an opportunity to maximise care for their patients after they depart the consulting room thanks to patient support...

People often turn to supplements or superfoods to ward off macular disease or prevent its progression, but new Australian nutritional...

The Australian eyecare sector is challenging the idea that vision loss with age is inevitable. This, combined with cutting-edge research...

RANZCO’s Referral Pathway for Age-Related Macular Degeneration (AMD) Management has been updated as Australia gears up for the first approved...

Apellis Pharmaceuticals has responded to “positive” 24-month data for its pioneering geographic atrophy (GA) therapy published in The Lancet, demonstrating...

An investigation into rare events of retinal vasculitis linked to Apellis Pharmaceutical’s new therapy, SYFOVRE, for geographic atrophy (GA) has...

Astellas Pharma has announced positive 24-month topline results from the GATHER2 Phase 3 clinical study of IZERVAY, developed by its...

Novartis will discontinue development of GT005 gene therapy, a subretinal injection for geographic atrophy (GA), in a blow to the...